Karmali, R., Galvez, C., Winter, J., Ma, S., Zhang, B., Xie, P., Ma, Y. (., Chen, R., Shah, N., Gordon, L. (2025). Phase II, single-arm, open-label, multicenter study: Efficacy of adjunctive Bruton's tyrosine kinase inhibitor (BTKi) zanubrutinib and chimeric antigen receptor (CART) in aggressive B-cell non-hodgkins lymphoma (aNHL). Blood. https://doi.org/10.1182/blood-2025-1010